Table 1 Basic characteristics of older hypertensive patients in Beijing, China
Characteristics | UEBMI | URRBMI | Total |
|---|---|---|---|
Total patients (%) | 1,294,363 (80.63) | 311,044 (19.37) | 1,605,407 (100.00) |
Male patients (%) | 645,039 (49.83) | 114,901 (36.94) | 759,940 (47.34) |
Age, patients (%) | |||
60 ~ 74 | 886,525 (68.49) | 222,599 (71.57) | 1,109,124 (69.09) |
75 ~ 89 | 383,203 (29.61) | 82,658 (26.57) | 465,861 (29.02) |
≥ 90 | 24,635 (1.90) | 5787 (1.86) | 30,422 (1.89) |
Number of outpatient visits | |||
Total | 18,762,328 | 2,989,784 | 21,752,112 |
Each patient | 14.50 | 9.61 | 13.55 |
Observation time, days | |||
Total | 378,847,830 | 84,138,589 | 462,986,419 |
Each patient | 292.69 | 270.50 | 288.39 |
Outpatient expenditures, Chinese yuan | |||
Total | 10,347,701,479 | 768,666,046 | 11,116,367,525 |
Each visit | 551.51 | 257.10 | 511.05 |
Antihypertensive medications, visits (%) | 11,799,646 (62.89) | 2,098,148 (70.18) | 13,897,794 (63.89) |
Thiazide diuretics | 2,060,005 (17.46) | 546,382 (26.04) | 2,606,387 (18.75) |
Calcium channel blockers | 7,346,310 (62.26) | 1,238,377 (59.02) | 8,584,687 (61.77) |
ARBs | 5,141,735 (43.58) | 870,842 (41.51) | 6,012,577 (43.26) |
ACE inhibitors | 930,643 (7.89) | 146,684 (6.99) | 1,077,327 (7.75) |
Beta blockers | 3,090,159 (26.19) | 372,988 (17.78) | 3,463,147 (24.92) |